CN116082214A - 2-aryl-3-tert-butylindole compound, preparation method and application thereof - Google Patents

2-aryl-3-tert-butylindole compound, preparation method and application thereof Download PDF

Info

Publication number
CN116082214A
CN116082214A CN202310161075.7A CN202310161075A CN116082214A CN 116082214 A CN116082214 A CN 116082214A CN 202310161075 A CN202310161075 A CN 202310161075A CN 116082214 A CN116082214 A CN 116082214A
Authority
CN
China
Prior art keywords
aryl
compound
tert
butylindole
added
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202310161075.7A
Other languages
Chinese (zh)
Inventor
王建军
史一安
胡大国
孙小凤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Changzhou University
Original Assignee
Changzhou University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Changzhou University filed Critical Changzhou University
Priority to CN202310161075.7A priority Critical patent/CN116082214A/en
Publication of CN116082214A publication Critical patent/CN116082214A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Indole Compounds (AREA)

Abstract

The invention discloses a 2-aryl-3-tert-butylindole compound, a preparation method and application thereof, trifluoroacetic acid is used as a catalyst, 1, 3-hexafluoro-2-propanol is used as a solvent, N-tert-butyl protection-2-arylindole compound is used as a substrate, and the tert-butyl migration reaction catalyzed by acid can realize the migration of tert-butyl protecting group from N1 position to C3 position to form a new C-C bond, so that the C2 and C3-position disubstituted indole compound can be effectively synthesized. The reaction condition is mild, the operation is simple and convenient, and the yield is up to 88%.

Description

2-aryl-3-tert-butylindole compound, preparation method and application thereof
Technical Field
The invention belongs to the field of indole compounds, and in particular relates to a preparation method and application of a 2-aryl-3-tert-butylindole compound.
Background
Indole is widely used as an important structural skeleton in a plurality of active molecules such as natural products, medicines, pesticides, materials and the like, so that a new method for efficiently synthesizing indole derivatives is attracting attention of a plurality of chemists. The 2, 3-disubstituted indole is an important indole derivative, and has important application prospect in the fields of medicine, material development and the like.
Disclosure of Invention
The invention aims to provide a preparation method of a 2-aryl-3-tertiary butyl indole compound, which uses an N-tertiary butyl-2-aryl indole compound as a substrate and trifluoroacetic acid as a catalyst; by acid-catalyzed t-butyl migration, t-butyl alkylation of the C3 position of indole (i.e., migration of the t-butyl protecting group from the N1 position to the C3 position to form a new C-C bond) can be successfully achieved, and a 2, 3-disubstituted indole compound is constructed. The prepared 2-aryl-3-tertiary butyl indole compounds can be used for preparing bioactive molecules
In order to achieve the above purpose, the invention is realized by the following technical scheme:
a preparation method of 2-aryl-3-tert-butylindole compounds, wherein the indole compounds are compounds shown in a formula I,
Figure BDA0004094163760000011
the preparation method comprises the following steps:
in an inert atmosphere, mixing and reacting the N-tertiary butyl-2-aryl substituted indole compound shown in the formula II in a first organic solvent to obtain a compound I;
Figure BDA0004094163760000021
in the formula I and the formula II: r is one of hydrogen, methyl, methoxy, ester group or phenyl, and X is one of hydrogen, 4-fluoro, 5-methyl, 5-ester group, 6-methoxy, 6-fluoro, 6-ester group and 6-phenyl.
Preferably, the indole compound is any one of compounds shown in the following formulas I-a-I-m:
Figure BDA0004094163760000022
preferably, the molar ratio of the N-tertiary butyl-2-aryl substituted indole compound II to the trifluoroacetic acid is 1:0.2.
Preferably, the concentration of the N-tertiary butyl-2-aryl substituted indole compound II in the mixed solution of the N-tertiary butyl-2-aryl substituted indole compound II, trifluoroacetic acid and the first organic solvent is 0.2 mol/L.
Preferably, the first organic solvent is 1, 3-hexafluoro-2-propanol.
Preferably, the reaction time is 3-7 hours and the temperature is room temperature.
Preferably, the reaction time is 3 hours and the temperature is room temperature.
Preferably, the N-tert-butyl-2-aryl-substituted indole compound II is added into a reaction vessel, a first organic solvent 1, 3-hexafluoro-2-propanol is added, and then trifluoroacetic acid is added dropwise and stirred at room temperature for 3 hours, and K is added 2 CO 3 The reaction was quenched with aqueous solution and extracted with ethyl acetate.
Preferably, the 2-aryl-3-tert-butylindole compound is purified by column chromatography, and the column solvent is petroleum ether; the column packing used was 300-400 mesh silica gel with a specification of 1cm diameter by 15cm height.
Preferably, the 2-aryl-3-tert-butylindole compound is purified by column chromatography, and the column solvent is petroleum ether; the eluent is petroleum ether: dichloromethane.
2-aryl-3-tert-butylindole compound with general formula I
Figure BDA0004094163760000031
Wherein: r is one of hydrogen, methyl, methoxy, ester group or phenyl, and X is one of hydrogen, 4-fluoro, 5-methyl, 5-ester group, 6-methoxy, 6-fluoro, 6-ester group and 6-phenyl.
Preferably, the indole compound is any one of compounds shown in the following formulas I-a-I-m:
Figure BDA0004094163760000041
the application of the 2-aryl-3-tert-butylindole compound in preparing bioactive molecules.
Compared with the prior art, the invention has the beneficial effects that:
(1) The 2-aryl-3-tert-butyl substituted indole compound has the advantages of easily available raw materials, simple and convenient operation, and simple and efficient synthesis by the existing method.
(2) According to the invention, N-tertiary butyl-2-aryl substituted indole compounds II with different structures are used as raw materials, trifluoroacetic acid is used as a catalyst, and a series of 2, 3-disubstituted indole compounds can be successfully synthesized through migration of N-tertiary butyl at N1 to C3 positions. The method has the advantages of easy synthesis of raw materials, mild reaction conditions, simple operation and high yield up to 88%.
Detailed Description
Preferred embodiments of the present invention will be described in more detail below in connection with specific examples. The methods are conventional methods unless otherwise specified. The starting materials are commercially available from the public unless otherwise specified. In the column chromatography step of the following examples, the column was packed with 300-400 mesh silica gel having a size of 1cm diameter by 1.5cm diameter by 20cm height.
Example 1
A2-aryl-3-tert-butylindole compound shown in a formula I-a is prepared by the following steps:
Figure BDA0004094163760000051
compound II-a (0.0623 g,0.25 mmol) was added to the reaction vessel, a first organic solvent 1, 3-hexafluoro-2-propanol (1.2 ml) was added, followed by dropwise addition of trifluoroacetic acid (3.7. Mu.l, 0.05 mmol) and stirring at room temperature for 3h 1M K was added 2 CO 3 Quenching the reaction with water solution and extracting with ethyl acetate; the organic phase was washed with saturated brine and dried over anhydrous sodium carbonate, filtered, concentrated and further purified by column chromatography under the following conditions: petroleum ether is packed into a column, and the eluent is petroleum ether: dichloromethane (5:1); obtain I-a pale yellow solid (0.0450 g,72% yield).
The structure validation results are as follows: 1 H NMR(400MHz,CDCl 3 )δ7.94(d,J=8.4Hz,1H),7.73(br s,1H),7.48-7.44(m,2H),7.44-7.38(m,3H),7.31(d,J=8.0Hz,1H),7.20(td,J=7.2and 1.2Hz,1H),7.14(td,J=8.0and 1.2Hz,1H),1.39(s,9H); 13 C NMR(100MHz,CDCl 3 )δ136.6,135.8,133.5,131.0,128.3,127.7,127.5,122.3,121.8,121.6,119.0,110.8,33.3,32.5。
the compound synthesized by structural identification is 2-phenyl-3-tertiary butyl-1H-indole shown as a target compound I-a.
Example 2
A2-aryl-3-tert-butylindole compound shown in the formula I-b is prepared by the following steps:
Figure BDA0004094163760000052
compound II-l (0.0658 g,0.25 mmol) was added to the reaction vessel, a first organic solvent 1, 3-hexafluoro-2-propanol (1.2 ml) was added, followed by dropwise addition of trifluoroacetic acid (3.7. Mu.l, 0.05 mmol) and stirring at room temperature for 3h. 1M K was added 2 CO 3 Quenching the reaction with water solution and extracting with ethyl acetate; the organic phase was washed with saturated brine and dried over anhydrous sodium carbonate, filtered, concentrated and further purified by column chromatography under the following conditions: loading petroleum ether into a column, wherein the eluent is petroleum ether; i-l white solid (0.0510 g,77% yield) was obtained.
The structure validation results are as follows: 1 H NMR(400MHz,CDCl 3 )δ7.91(d,J=8.0Hz,1H),7.70(br s,1H),7.36-7.28(m,3H),7.22-7.15(m,3H),7.15-7.09(m,1H),2.43(s,3H),1.38(s,9H); 13 C NMR(100MHz,CDCl 3 ) Delta 138.1,135.8,133.63,133.55,130.9,128.4,127.6,122.3,121.7,121.5,118.9,110.7,33.3,32.5,21.5; the compound synthesized by structural identification is 2-p-tolyl-3-tert-butyl-1H-indole shown as a target compound I-b.
Example 3
A2-aryl-3-tert-butylindole compound shown in the formula I-c is prepared by the following steps:
Figure BDA0004094163760000061
compound II-c (0.0658 g,0.25 mmol) was added to the reaction vessel, a first organic solvent 1, 3-hexafluoro-2-propanol (1.2 ml) was added, followed by dropwise addition of trifluoroacetic acid (3.7. Mu.l, 0.05 mmol) and stirring at room temperature for 3h. 1M K was added 2 CO 3 Quenching the reaction with water solution and extracting with ethyl acetate; the organic phase was washed with saturated brine and dried over anhydrous sodium carbonate, filtered, concentrated and further purified by column chromatography under the following conditions: petroleum ether is packed into a column, and the eluent is petroleum ether: dichloromethane (15:1); i-c was obtained as a white solid (0.0520 g,79% yield).
The structure validation results are as follows: 1 H NMR(400MHz,CDCl 3 )δ7.92(d,J=8.0Hz,1H),7.71(br s,1H),7.33-7.21(m,5H),7.21-7.16(m,1H),7.15-7.10(m,1H),2.42(s,3H),1.39(s,9H); 13 C NMR(100MHz,CDCl 3 ) Delta 137.3,136.5,135.8,133.7,131.7,129.0,128.2,127.6,127.5,122.3,121.6,121.5,119.0,110.7,33.3,32.5,21.5; the compound synthesized by structural identification is 2-m-tolyl-3-tert-butyl-1H-indole shown as a target compound I-b.
Example 4
A2-aryl-3-tert-butylindole compound shown in the formula I-d is prepared by the following steps:
Figure BDA0004094163760000071
compound II-d (0.0698 g,0.25 mmol) was added to the reaction vessel, a first organic solvent 1, 3-hexafluoro-2-propanol (1.2 ml) was added, followed by dropwise addition of trifluoroacetic acid (3.7. Mu.l, 0.05 mmol) and stirring at room temperature for 3h. 1M K was added 2 CO 3 Quenching the reaction with water solution and extracting with ethyl acetate; the organic phase was washed with saturated brine and dried over anhydrous sodium carbonate, filtered, concentrated and further purified by column chromatography under the following conditions: petroleum ether is packed into a column, and the eluent is petroleum ether: dichloromethane (5:1); i-d white (0.050 g,72% yield) was obtained.
The structure validation results are as follows: 1 H NMR(400MHz,CDCl 3 )δ7.91(d,J=8.0Hz,1H),7.71(br s,1H),7.39-7.33(m,2H),7.30(d,J=8.0Hz,1H),7.20-7.15(m,1H),7.14-7.09(m,1H),6.94-6.89(m,2H),3.87(s,3H),1.37(s,9H); 13 CNMR(100MHz,CDCl 3 ) Delta 159.6,135.7,133.3,132.1,128.7,127.6,122.3,121.8,121.5,118.9,113.1,110.7,55.4,33.3,32.5; the compound synthesized by structural identification is 2-p-methoxyphenyl-3-tertiary butyl-1H-indole shown as a target compound I-d.
Example 5
A2-aryl-3-tert-butylindole compound shown in the formula I-e is prepared by the following steps:
Figure BDA0004094163760000081
compound II-e (0.0762 g,0.25 mmol) was added to the reaction vessel, a first organic solvent 1, 3-hexafluoro-2-propanol (1.2 ml) was added, followed by dropwise addition of trifluoroacetic acid (3.7. Mu.l, 0.05 mmol) and stirring at room temperature for 3h. 1M K was added 2 CO 3 Quenching the reaction with water solution and extracting with ethyl acetate; the organic phase was washed with saturated brine and dried over anhydrous sodium carbonate, filtered, concentrated and further purified by column chromatography under the following conditions: petroleum ether is packed into a column, and the eluent is petroleum ether: dichloromethane (2:1); i-f white solid (0.0480 g,63% yield) was obtained.
The structure validation results are as follows: 1 H NMR(400MHz,CDCl 3 )δ8.05(d,J=8.0Hz,2H),7.93(d,J=8.0Hz,1H),7.87(br s,1H),7.53(d,J=8.0Hz,2H),7.33(d,J=7.2Hz,1H),7.2(t,J=7.2Hz,1H),7.17-7.10(m,1H),3.96(s,3H),1.37(s,9H); 13 C NMR(100MHz,CDCl 3 ) Delta 167.0,141.5,136.1,132.2,131.1,129.9,128.9,127.5,122.5,122.4,122.0,119.2,110.9,52.4,33.3,32.5; the compound synthesized by structural identification is 2- (4-methyl formate phenyl) -3-tertiary butyl-1H-indole shown as a target compound I-e.
Example 6
A2-aryl-3-tert-butylindole compound shown in the formula I-f is prepared by the following steps:
Figure BDA0004094163760000082
compound II-i (0.0749 g,0.25 mmol) was added to the reaction vessel, a first organic solvent 1, 3-hexafluoro-2-propanol (1.2 ml) was added, followed by dropwise addition of trifluoroacetic acid (3.7. Mu.l, 0.05 mmol) and stirring at room temperature for 3h. 1M K was added 2 CO 3 Quenching the reaction with water solution and extracting with ethyl acetate; the organic phase was washed with saturated brine and dried over anhydrous sodium carbonate, filtered, concentrated and further purified by column chromatography under the following conditions: petroleum ether is packed into a column, and the eluent is petroleum ether: dichloromethane (15:1); i-f white solid (0.0570 g,76% yield) was obtained.
The structure validation results are as follows: 1 H NMR(400MHz,CDCl 3 )δ7.96(d,J=8.0Hz,1H),7.94-7.85(m,4H),7.79(br s,1H),7.62-7.52(m,3H),7.34(d,J=8.0Hz,1H),7.22(t,J=7.2Hz,1H),7.19-7.13(m,1H),1.41(s,9H); 13 C NMR(100MHz,CDCl 3 ) Delta 135.9,134.0,133.4,133.0,132.7,129.9,129.1,128.2,127.9,127.6,127.1,126.63,126.60,122.4,122.2,121.7,119.1,110.8,33.4,32.6; the compound synthesized by structural identification is 2- (2-naphthyl) -3-tertiary butyl-1H-indole shown as a target compound I-f.
Example 7
A2-aryl-3-tert-butylindole compound shown in the formula I-g is prepared by the following steps:
Figure BDA0004094163760000091
compound II-i (0.2674 g,0.75 mmol) was added to the reaction vessel, a first organic solvent 1, 3-hexafluoro-2-propanol (3.6 ml) was added, followed by dropwise addition of trifluoroacetic acid (11.1. Mu.l, 0.15 mmol) and stirring at room temperature for 3h 1M K was added 2 CO 3 Quenching the reaction with water solution and extracting with ethyl acetate; the organic phase was washed with saturated brine and was then washed with brineDrying sodium carbonate hydrate, filtering, concentrating and purifying by column chromatography, wherein the specific conditions are as follows: petroleum ether is packed into a column, and the eluent is petroleum ether: dichloromethane (6:1); i-g white solid (0.140 g,70% yield) was obtained.
The structure validation results are as follows: 1 H NMR(400MHz,CDCl 3 )δ7.77(br s,1H),7.48-7.36(m,5H),7.17-7.04(m,2H),6.89-6.78(m,1H),1.34(d,J=3.2Hz,9H); 13 C NMR(100MHz,CDCl 3 ) Delta 156.1 (d, j= 244.9 Hz), 138.5 (d, j=11.7 Hz), 136.2,133.6,131.0,128.5,127.7,122.6 (d, j=9.0 Hz), 121.6 (d, j=4.2 Hz), 116.2 (d, j=18.9 Hz), 106.7 (d, j=3.4 Hz), 105.7 (d, j=24.5 Hz), 32.9 (d, j=7.2 Hz), 32.5; the compound synthesized by structural identification is 2-phenyl-3-tertiary butyl-4-fluoro-1H-indole shown as a target compound I-m.
Example 8
A2-aryl-3-tert-butylindole compound shown in the formula I-h is prepared by the following steps:
Figure BDA0004094163760000101
compound II-h (0.0659 g,0.25 mmol) was added to the reaction vessel, a first organic solvent 1, 3-hexafluoro-2-propanol (1.2 ml) was added, followed by dropwise addition of trifluoroacetic acid (3.7. Mu.l, 0.05 mmol) and stirring at room temperature for 3h 1M K was added 2 CO 3 Quenching the reaction with water solution and extracting with ethyl acetate; the organic phase was washed with saturated brine and dried over anhydrous sodium carbonate, filtered, concentrated and further purified by column chromatography under the following conditions: petroleum ether is packed into a column, and the eluent is petroleum ether: dichloromethane (5:1); i-h white solid (0.0470 g,72% yield) was obtained.
The structure validation results are as follows: 1 H NMR(400MHz,CDCl 3 )δ7.70(s,1H),7.63(br s,1H),7.47-7.43(m,2H),7.42-7.36(m,3H),7.20(d,J=8.4Hz,1H),7.02(d,J=8.4Hz,1H),2.51(s,3H),1.38(s,9H); 13 C NMR(100MHz,CDCl 3 ) Delta 136.8,134.2,133.7,131.0,128.2,128.1,127.8,127.6,123.1,122.0,121.4,110.4,33.3,32.5,22.0; the compound synthesized by structural identification is 2-percent of target compound I-hphenyl-3-tert-butyl-5-methyl-1H-indole.
Example 9
A2-aryl-3-tert-butylindole compound shown in the formula I-I is prepared by the following steps:
Figure BDA0004094163760000111
compound II-i (0.0769 g,0.25 mmol) was added to the reaction vessel, a first organic solvent 1, 3-hexafluoro-2-propanol (1.2 ml) was added, followed by dropwise addition of trifluoroacetic acid (3.7. Mu.l, 0.05 mmol) and stirring at room temperature for 3h. 1M K was added 2 CO 3 Quenching the reaction with water solution and extracting with ethyl acetate; the organic phase was washed with saturated brine and dried over anhydrous sodium carbonate, filtered, concentrated and further purified by column chromatography under the following conditions: petroleum ether is packed into a column, and the eluent is petroleum ether: dichloromethane (2:1); I-I white solid (0.0650 g,85% yield) was obtained.
The structure validation results are as follows: 1 H NMR(400MHz,CDCl 3 )δ8.68(s,1H),7.95(br s,1H),7.89(d,J=8.4Hz,1H),7.46-7.37(m,5H),7.30(d,J=8.8Hz,1H),3.95(s,3H),1.38(s,9H); 13 C NMR(100MHz,CDCl 3 )δ168.5,138.4,135.8,134.7,130.9,128.6,127.8,127.2,125.3,123.22,123.16,121.0,110.3,52.0,33.3,32.6.
the compound synthesized by structural identification is 2-phenyl-3-tertiary butyl-1H-indole-5-methyl formate shown as a target compound I-I.
Example 10
A2-aryl-3-tert-butylindole compound shown in the formula I-j is prepared by the following steps:
Figure BDA0004094163760000112
compound II-j ((0.0668 g,0.25 mmol) was added to the reaction vessel, first organic solvent 1, 3-hexafluoro-2-propanol (1.2 ml) was added, followed by dropwise addition of trifluoroacetic acid (3.7. Mu.l, 0.05 mmol) and stirring at room temperature for 3h. 1M K was added 2 CO 3 Quenching the reaction with water solution and extracting with ethyl acetate; the organic phase was washed with saturated brine and dried over anhydrous sodium carbonate, filtered, concentrated and further purified by column chromatography under the following conditions: petroleum ether is packed into a column, and the eluent is petroleum ether: dichloromethane (10:1); i-j white solid (0.0510 g,76% yield) was obtained.
The structure validation results are as follows: 1 H NMR(400MHz,CDCl 3 )δ7.81(dd,J=8.8and5.2Hz,1H),7.71(br s,1H),7.47-7.38(m,5H),6.98(dd,J=9.6,2.4Hz,1H),6.89(td,J=9.2,2.8Hz,1H),1.35(d,J=3.2Hz,9H); 13 C NMR(100MHz,CDCl 3 ) δ 159.6 (d, j=236.0 Hz), 136.2,135.8 (d, j=12.0 Hz), 133.8 (d, j=4.0 Hz), 131.0,128.4,127.8,124.1,123.0 (d, j=9.0 Hz), 121.8,107.6 (d, j=23.0 Hz), 96.9 (d, j=25.0 Hz), 33.2,32.5; the compound synthesized by structural identification is 2-phenyl-3-tertiary butyl-7-fluoro-1H-indole shown as a target compound I-j.
Example 11
A2-aryl-3-tert-butylindole compound shown in the formula I-k is prepared by the following steps:
Figure BDA0004094163760000121
compound II-k (0.0768 g,0.25 mmol) was added to the reaction vessel, a first organic solvent 1, 3-hexafluoro-2-propanol (1.2 ml) was added, followed by dropwise addition of trifluoroacetic acid (3.7. Mu.l, 0.05 mmol) and stirring at room temperature for 3h. 1M K was added 2 CO 3 Quenching the reaction with water solution and extracting with ethyl acetate; the organic phase was washed with saturated brine and dried over anhydrous sodium carbonate, filtered, concentrated and further purified by column chromatography under the following conditions: petroleum ether is packed into a column, and the eluent is petroleum ether: diethyl ether (7:1); i-k white solid (0.0640 g,83% yield) was obtained.
The structure validation results are as follows: 1 H NMR(400MHz,CDCl 3 )δ8.14-8.02(m,2H),7.92(d,J=8.4Hz,1H),7.79(dd,J=8.8and 2.0Hz,1H),7.47-7.37(m,5H),3.92(s,3H),1.36(s,9H); 13 C NMR(100MHz,CDCl 3 )δ168.3,137.1,135.9,135.1,131.2,130.8,128.6,127.8,123.1,122.5,121.8,120.0,113.1,52.1,33.3,32.5; the compound synthesized by structural identification is 2-phenyl-3-tertiary butyl-1H-indole-7-methyl formate shown as a target compound I-k.
Example 12
A2-aryl-3-tert-butylindole compound shown in the formula I-l is prepared by the following steps:
Figure BDA0004094163760000131
compound II-l (0.0698 g,0.25 mmol) was added to the reaction vessel, a first organic solvent 1, 3-hexafluoro-2-propanol (1.2 ml) was added, followed by dropwise addition of trifluoroacetic acid (3.7. Mu.l, 0.05 mmol) and stirring at room temperature for 3h. 1M K was added 2 CO 3 Quenching the reaction with water solution and extracting with ethyl acetate; the organic phase was washed with saturated brine and dried over anhydrous sodium carbonate, filtered, concentrated and further purified by column chromatography under the following conditions: petroleum ether is packed into a column, and the eluent is petroleum ether: dichloromethane (5:1); i-l white solid (0.0520 g,74% yield) was obtained.
The structure validation results are as follows: 1 H NMR(400MHz,CDCl 3 )δ7.78(d,J=9.6Hz,1H),7.63(br s,1H),7.47-7.42(m,2H),7.41-7.35(m,3H),6.85-6.75(m,2H),3.85(s,3H),1.35(s,9H); 13 C NMR(100MHz,CDCl 3 ) Delta 156.0,136.7,136.6,132.3,131.2,128.2,127.7,122.9,121.9,121.7,108.8,94.2,55.8,33.2,32.5; the compound synthesized by structural identification is 2-phenyl-3-tertiary butyl-7-methoxy-1H-indole shown as a target compound I-l.
Example 13
A2-aryl-3-tert-butylindole compound shown in the formula I-m is prepared by the following steps:
Figure BDA0004094163760000141
compound II-m (0.0814 g,0.25 mmol) was charged into a reaction vessel, and a first organic solvent 1, 3-hexafluoro-2-propanol (1.2 ml) was added, followed by the following stepsTrifluoroacetic acid (3.7. Mu.l, 0.05 mmol) was added dropwise and stirred at room temperature for 3h 1M K was added 2 CO 3 Quenching the reaction with water solution and extracting with ethyl acetate; the organic phase was washed with saturated brine and dried over anhydrous sodium carbonate, filtered, concentrated and further purified by column chromatography under the following conditions: petroleum ether is packed into a column, and the eluent is petroleum ether: dichloromethane (5:1); i-m white solid (0.0680 g,84% yield) was obtained.
The structure validation results are as follows: 1 H NMR(400MHz,CDCl 3 )δ7.97(d,J=8.0Hz,1H),7.81(br s,1H),7.69-7.64(m,2H),7.52(d,J=1.6Hz,1H),7.50-7.44(m,4H),7.44-7.37(m,5H),7.33(tt,J=7.6and 1.2Hz,1H),1.40(s,9H); 13 CNMR(100MHz,CDCl 3 ) Delta 142.4,136.43,136.37,135.2,134.3,131.0,128.8,128.4,127.7,127.5,126.9,126.7,122.5,121.9,118.9,109.2,33.3,32.5; the compound synthesized by structural identification is 2-phenyl-3-tertiary butyl-7-phenyl-1H-indole shown as a target compound I-m.

Claims (10)

1. A preparation method of 2-aryl-3-tert-butylindole compounds is characterized in that the indole compounds are compounds shown in a formula I,
Figure FDA0004094163720000011
the preparation method comprises the following steps:
in an inert atmosphere, mixing and reacting the N-tertiary butyl-2-aryl substituted indole compound shown in the formula II in a first organic solvent to obtain a compound I;
Figure FDA0004094163720000012
in the formula I and the formula II: r is one of hydrogen, methyl, methoxy, ester group or phenyl, and X is one of hydrogen, 4-fluoro, 5-methyl, 5-ester group, 6-methoxy, 6-fluoro, 6-ester group and 6-phenyl.
2. The method for preparing a 2-aryl-3-tert-butylindole compound according to claim 1, wherein the indole compound is any one of compounds represented by the following formulas i-a to i-m:
Figure FDA0004094163720000021
3. the method for preparing 2-aryl-3-tert-butylindole compound according to claim 1 or 2, wherein the molar ratio of N-tert-butyl-2-aryl substituted indole compound II to trifluoroacetic acid is 1:0.2.
4. The process for producing a 2-aryl-3-t-butylindole compound according to claim 1 or 2, wherein the concentration of the N-t-butyl-2-aryl-substituted indole compound II in the mixed solution of the N-t-butyl-2-aryl-substituted indole compound II, trifluoroacetic acid and the first organic solvent is 0.2 mol/l.
5. The method for producing a 2-aryl-3-tert-butylindole compound according to claim 1 or 2, wherein the first organic solvent is 1, 3-hexafluoro-2-propanol.
6. The process for producing a 2-aryl-3-t-butylindole compound according to claim 1 or 2, wherein the reaction time is 3 hours and the temperature is room temperature.
7. The process for preparing a 2-aryl-3-tert-butylindole compound according to claim 1 or 2, wherein in the preparation, N-tert-butyl-2-aryl-substituted indole compound II is added into a reaction vessel, a first organic solvent 1, 3-hexafluoro-2-propanol is added, and then trifluoroacetic acid is added dropwise and stirred at room temperature for 3 hours, and K is added 2 CO 3 The reaction is quenched by the water solution,and extracted with ethyl acetate.
8. A2-aryl-3-tert-butylindole compound is characterized in that the general formula of the indole compound is I
Figure FDA0004094163720000031
Wherein: r is one of hydrogen, methyl, methoxy, ester group or phenyl, and X is one of hydrogen, 4-fluoro, 5-methyl, 5-ester group, 6-methoxy, 6-fluoro, 6-ester group and 6-phenyl.
9. The 2-aryl-3-tert-butylindole compound according to claim 1, wherein the indole compound is any one of the following compounds represented by formulas i-a to i-m:
Figure FDA0004094163720000041
10. use of a 2-aryl-3-tert-butylindole compound according to any one of claims 1 to 9 for the preparation of a bioactive molecule.
CN202310161075.7A 2023-02-24 2023-02-24 2-aryl-3-tert-butylindole compound, preparation method and application thereof Pending CN116082214A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202310161075.7A CN116082214A (en) 2023-02-24 2023-02-24 2-aryl-3-tert-butylindole compound, preparation method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202310161075.7A CN116082214A (en) 2023-02-24 2023-02-24 2-aryl-3-tert-butylindole compound, preparation method and application thereof

Publications (1)

Publication Number Publication Date
CN116082214A true CN116082214A (en) 2023-05-09

Family

ID=86212066

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202310161075.7A Pending CN116082214A (en) 2023-02-24 2023-02-24 2-aryl-3-tert-butylindole compound, preparation method and application thereof

Country Status (1)

Country Link
CN (1) CN116082214A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013159229A1 (en) * 2012-04-24 2013-10-31 Dalhousie University Silanyloxyaryl phosphine ligand and uses thereof in c-n cross-coupling
CN113683551A (en) * 2021-09-09 2021-11-23 常州大学 N-tert-butyl-2-phenylindole derivative, preparation method and application

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013159229A1 (en) * 2012-04-24 2013-10-31 Dalhousie University Silanyloxyaryl phosphine ligand and uses thereof in c-n cross-coupling
CN113683551A (en) * 2021-09-09 2021-11-23 常州大学 N-tert-butyl-2-phenylindole derivative, preparation method and application

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACT SERVICE: "RN:2558437-02-6、2552338-48-2、2548251-88-1、2539233-68-4、2533419-92-8、2509965-69-7、2441613-70-1", CA网络版STN REGISTRY数据库, 14 December 2020 (2020-12-14) *
JIANJUN WANG等: "Pd-Catalyzed Indole Synthesis via C −H Activation and Bisamination Sequence with Diaziridinone", ORG. LETT., vol. 23, 15 September 2021 (2021-09-15), pages 7561 - 7565 *

Similar Documents

Publication Publication Date Title
CN109970755B (en) Synthesis of substituted salicylaldehyde derivatives
CN108467360B (en) Preparation method and intermediate of apatinib
CN110183378B (en) Nicotinamide derivative and catalytic synthesis method thereof
CN110878099B (en) Preparation method of pyrrole [1,2, alpha ] indole alkaloid derivative
CN116023359B (en) Synthesis method of aminothiophene compound and aminothiophene compound
CN109651271B (en) Synthetic method of 3-tert-butyl-N-methylquinoxaline-2 (1H) -ketone compound
CN116082214A (en) 2-aryl-3-tert-butylindole compound, preparation method and application thereof
RU2709493C1 (en) Method of producing roxadustat
CN113511986A (en) Preparation method of aryl acetonitrile derivative
CN113603694A (en) 1, 2-diketone compound and preparation method and application thereof
CN113501771A (en) Preparation method of N- (2-aminoethyl) glycine derivative
CN107892668B (en) A kind of synthetic method of quinoline
CN111909148A (en) Indolizine derivative and preparation method thereof
CN113045575B (en) Preparation method of compound, intermediate thereof and preparation method of intermediate
CN115304557B (en) Enamine derivative and preparation method thereof
CN116462619B (en) Preparation method of cyclopentenone derivative
CN115626861B (en) Method for synthesizing trifluoromethyl aromatic compound
JPS60237039A (en) Benzalacetophenone, its derivative and their production
CN115286566B (en) Synthesis method of pheniramine or derivatives thereof
CN110128340B (en) Synthesis method of quinolinone compounds
CN112441935B (en) Synthesis method of beta-aminoketone compound
CN107162999B (en) Synthetic method of 2-phenyl-4-p-hydroxyphenyl thiazole
CN110194760B (en) Process for preparing 3-benzylidene-2- (7' -quinoline) -2, 3-dihydro-isoindol-1-ones
CN117534613A (en) Preparation method of 3-aminopyridine-2-carboxylic acid methyl ester
CN107628996B (en) Synthesis method of polysubstituted quinoline

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination